Correlation Between Unibail Rodamco and Medical Developments
Can any of the company-specific risk be diversified away by investing in both Unibail Rodamco and Medical Developments at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unibail Rodamco and Medical Developments into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unibail Rodamco Westfield SE and Medical Developments International, you can compare the effects of market volatilities on Unibail Rodamco and Medical Developments and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unibail Rodamco with a short position of Medical Developments. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unibail Rodamco and Medical Developments.
Diversification Opportunities for Unibail Rodamco and Medical Developments
0.11 | Correlation Coefficient |
Average diversification
The 3 months correlation between Unibail and Medical is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Unibail Rodamco Westfield SE and Medical Developments Internati in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medical Developments and Unibail Rodamco is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unibail Rodamco Westfield SE are associated (or correlated) with Medical Developments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medical Developments has no effect on the direction of Unibail Rodamco i.e., Unibail Rodamco and Medical Developments go up and down completely randomly.
Pair Corralation between Unibail Rodamco and Medical Developments
Assuming the 90 days trading horizon Unibail Rodamco Westfield SE is expected to generate 0.79 times more return on investment than Medical Developments. However, Unibail Rodamco Westfield SE is 1.27 times less risky than Medical Developments. It trades about -0.03 of its potential returns per unit of risk. Medical Developments International is currently generating about -0.06 per unit of risk. If you would invest 629.00 in Unibail Rodamco Westfield SE on September 14, 2024 and sell it today you would lose (27.00) from holding Unibail Rodamco Westfield SE or give up 4.29% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Unibail Rodamco Westfield SE vs. Medical Developments Internati
Performance |
Timeline |
Unibail Rodamco West |
Medical Developments |
Unibail Rodamco and Medical Developments Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unibail Rodamco and Medical Developments
The main advantage of trading using opposite Unibail Rodamco and Medical Developments positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unibail Rodamco position performs unexpectedly, Medical Developments can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medical Developments will offset losses from the drop in Medical Developments' long position.Unibail Rodamco vs. Prime Financial Group | Unibail Rodamco vs. Qbe Insurance Group | Unibail Rodamco vs. Medibank Private | Unibail Rodamco vs. Finexia Financial Group |
Medical Developments vs. Aneka Tambang Tbk | Medical Developments vs. BHP Group Limited | Medical Developments vs. Rio Tinto | Medical Developments vs. Macquarie Group Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data |